2011
DOI: 10.2147/hiv.s8993
|View full text |Cite
|
Sign up to set email alerts
|

Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level

Abstract: Remarkable advances in the treatment of human immunodeficiency virus (HIV) disease have been blunted by widespread suboptimal adherence (ie, nonadherence), which has emerged as a major barrier to achieving the primary goal of antiretroviral (ARV) therapy: suppression of HIV viral load. Nonsuppressed HIV viral load is associated with drug resistance, increased morbidity and mortality, and a higher risk of person-to-person HIV transmission. For HIV-infected individuals who are failing HIV treatment due to nonadh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
38
0
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(41 citation statements)
references
References 64 publications
(44 reference statements)
1
38
0
2
Order By: Relevance
“…Although the number of people accessing antiretroviral drugs in developed places, such as North America and western and central Europe, is significantly higher than in Africa, drug adherence remains another barrier to successful treatment of HIV . Over one‐third of HIV‐infected people in developed countries have difficulty adhering to their drug regimens, resulting in negative consequences, including development of drug resistance, nonsuppressed viral loads, and increased risk of transmission to others . Although confounding factors, such as mental illness or substance abuse, are known to impact ART adherence, the stigma associated with HIV/AIDS is cited as a major culprit of nonadherence .…”
Section: Barriers To Successful Treatmentmentioning
confidence: 99%
“…Although the number of people accessing antiretroviral drugs in developed places, such as North America and western and central Europe, is significantly higher than in Africa, drug adherence remains another barrier to successful treatment of HIV . Over one‐third of HIV‐infected people in developed countries have difficulty adhering to their drug regimens, resulting in negative consequences, including development of drug resistance, nonsuppressed viral loads, and increased risk of transmission to others . Although confounding factors, such as mental illness or substance abuse, are known to impact ART adherence, the stigma associated with HIV/AIDS is cited as a major culprit of nonadherence .…”
Section: Barriers To Successful Treatmentmentioning
confidence: 99%
“…These fall into broad categories including psychosocial issues, economic factors, substance abuse, co-morbidities including psychiatric disease, low health literacy, and medication-related issues. Many of these factors are modifiable with adherence enhancing interventions [3].…”
Section: Introductionmentioning
confidence: 99%
“…So, the complexity of drug regimen, concerns for side effects might affect the day-to-day activities, which might be associated with non-adherence in COPD as suggested by other studies. 11,16,39 Such kind of problems is often encountered in various other chronic diseases like diabetes, 42 Hypertension, 59 human immunedeficiency virus-acquired immune-deficiency syndrome (HIV-AIDS), 60,61 and Tuberculosis as well.…”
mentioning
confidence: 99%